Skip to Main Content

Paper Details

Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study).
Am J Cardiol
7
2021
Angiotensin-Converting Enzyme 2, Atherosclerosis, CVD, Cardiovascular, N, N-terminal pro-B-type, aldosterone, angiotensin, angiotensin-converting enzyme 2, cardiac injury, cardiovascular disease, diabetes, heart failure, high-sensitivity cardiac troponin I and T, hypertension, impaired diastolic function, men, natriuretic peptide, participants, renin, sACE2, soluble ACE2
Author NameAffiliation
Xiaoming JiaBaylor College of Medicine
Elizabeth SelvinDepartment of Epidemiology and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health
Vijay NambiBaylor College of Medicine, Texax Center for Cardiometabolic Disease Prevention, Michael E. DeBakey Veterans Affairs Medical Center
Aaron R FolsomUniversity of Minnesota
Thomas H MosleyUniversity of Mississippi Medical Center
Salim S ViraniBaylor College of Medicine, Texax Center for Cardiometabolic Disease Prevention, Michael E. DeBakey Veterans Affairs Medical Center
Josef CoreshDepartment of Epidemiology and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health
Eric BoerwinkleSchool of Public Health, University of Texas Health Science Center at Houston
Eric BoerwinkleSchool of Public Health, University of Texas Health Science Center at Houston
Christie M BallantyneBaylor College of Medicine, Texax Center for Cardiometabolic Disease Prevention
Christie M BallantyneBaylor College of Medicine, Texax Center for Cardiometabolic Disease Prevention
  • 1 - 11

Datasets

Release 1.2